Top Markets
Coin of the day
Biotest AG Biotest AG

Biotest AG

BIO
Classifica tra le azioni #7311
Biotest AG is a German biopharmaceutical company focused on the global... Biotest AG is a German biopharmaceutical company focused on the global development, manufacturing, and commercialization of biological medications. The firm organizes its activities into the Therapy, Plasma & Services, and Other segments. Its product portfolio addresses critical needs in hematology, clinical immunology, and intensive care medicine. Among its offerings are treatments for hemophilia A (such as Haemoctin and Vihuma) and hemophilia B (like Haemonine), covering both acute care and prevention. Biotest also provides therapies for various viral infections, including cytomegalovirus (Cytotect CP), hepatitis B (Fovepta, Hepatect, Zutectra), and varicella zoster (Varitect). Additionally, its products, such as Intratect and IgG Next Generation, are utilized for primary and secondary immune deficiencies, autoimmune disorders, and certain neurological conditions. The company further supplies solutions to manage circulating blood volume (Albiomin, Biseko), address clotting factor deficiencies (Cofact, Fibrinogen), and combat serious infections like community-acquired pneumonia and COVID-19 (Trimodulin), as well as general bacterial infections (Pentaglobin). Established in 1946 as Biotest Serum-Institut GmbH, the company adopted its current name, Biotest Aktiengesellschaft, in 1986. Headquartered in Dreieich, Germany, Biotest Aktiengesellschaft has been operating as a subsidiary of Grifols, S.A. since January 21, 2022.
Prezzo delle azioni
$47.45
Ultima sincronizzazione: 2026-05-13
Capitalizzazione di mercato
$1.63B
Variazione (1 giorno)
2.04%
Variazione (1 anno)
3.15%
Paese
DE
Scambia Biotest AG (BIO)

Categoria

Storico del prezzo dell'azione per Biotest AG (BIO)
Prezzo di chiusura più alto: $47.86 il 2026-05-01

Prezzo di chiusura più basso: $6.49 il 1998-11-01
Storico del prezzo dell'azione di Biotest AG dal 1998 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 4.97%
2025 -1.89%
2024 -6.52%
2023 1.79%
2022 -5.71%
2021 41.57%
2020 54.29%
2019 -25.81%
2018 8.86%
2017 57.83%
2016 -6.25%
2015 -48.27%
2014 5.79%
2013 52.48%
2012 28.11%
2011 -13.50%
2010 6.55%
2009 -15.37%
2008 22.41%
2007 46.70%
2006 31.41%
2005 82.28%
2004 76.04%
2003 68.97%
2002 -56.60%
2001 -19.56%
2000 3.02%
1999 -24.95%
1998 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$548.36 39.87%
US
$1.06K 50.29%
NL
$121.53 -12.48%
AU
$140.81 475.44%
US
$762.91 7.41%
CH